Trials / Not Yet Recruiting
Not Yet RecruitingNCT06458725
Assessment of DW-MRI Measures : Reproducibility and Repeatability in Pelvic Imaging on MR-Linac With Healthy Volunteers
Comprehensive Assessment of Diffusion-Weighted Magnetic Resonance Imaging (DW-MRI) Measures: Reproducibility and Repeatability in Pelvic Imaging on MR-Linac With Healthy Volunteers. (PILLAR)
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Jules Bordet Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study evaluates the reliability of functional MRI measurements in pelvic disease through quantifying repeatability and reproducibility, using healthy volunteers. The aim is to provide insights into the consistency of results across sessions and observers, informing the trustworthiness of functional MRI in assessing pelvic disease and particularly rectal cancers and guiding protocol optimization.
Detailed description
Volunteers will be required to complete a questionnaire to ensure their eligibility and safety for undergoing an MRI. This questionnaire, along with safety information, will be reviewed before each MR session. Subsequently, volunteers will undergo three MRI sessions, ideally two on the same day, with the last session scheduled 10 to 17 days apart from the previous ones. Each session is expected to last approximately 60 minutes (several sequences), and no contrast agent will be injected at any point. On the first day, volunteers will have an MRI on the 1.5 Tesla MR-Linac Unity (Elekta device) and an MRI on a standard 1.5 Tesla MRI (Siemens). Between days 10 to 17, they will exclusively undergo an MR-Linac session.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Magnetic Resonance Imaging (MRI) | \- Three MRI : * two on an MR-Linac 1.5 Tesla (10 to 17 days apart) * one on a standard 1.5 Tesla MRI |
Timeline
- Start date
- 2024-06-13
- Primary completion
- 2024-09-01
- Completion
- 2024-11-01
- First posted
- 2024-06-14
- Last updated
- 2024-06-14
Source: ClinicalTrials.gov record NCT06458725. Inclusion in this directory is not an endorsement.